Scarica l'app Stockscreener
50.11
2.75%
1.34
Pre-mercato:
51.88
1.77
+3.53%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché MRNA Giù?
Forum
Previsione
Moderna Inc Borsa (MRNA) Ultime notizie
(MRNA) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Messenger RNA (mRNA) Market Projected to Reach $20.99 - GlobeNewswire
Moderna stock consolidates as short-term sellers dominate near $53.35 resistance - Traders Union
RBC Adjusts Price Target on Moderna to $35 From $30, Maintains Sector Perform Rating - marketscreener.com
Spikevax Vaccine: Key Role in mRNA COVID Protection - AD HOC NEWS
Moderna Inc (MRNA) Stock Price Quote Today & Current Price Chart - Capital.com
Moderna to Present Revaccination Data for Its Investigational Seasonal Influenza Vaccine and for mRESVIA at ESCMID 2026 - Rutland Herald
New Moderna data tests repeat flu and RSV shots in older adults - Stock Titan
Moderna (MRNA) CFO vests RSUs, 703 shares withheld for tax - Stock Titan
Moderna, Inc. (MRNA) stock price, news, quote and history - Yahoo Finance UK
Moderna: Speculative Buy For Aggressive Investors Betting On mRNA's Future (NASDAQ:MRNA) - Seeking Alpha
Jim Cramer Discusses the Moderna Rally and the Impact of FDA Leadership Changes - Insider Monkey
Is Moderna (MRNA) Pricing Make Sense After A 96% One Year Share Price Jump - Yahoo Finance
Top Moderna Shareholders - Investopedia
Hims & Hers Health, Regeneron, Biogen, BioMarin Pharmaceutical, and Moderna Shares Are Falling, What You Need To Know - Yahoo Finance
Moderna (MRNA) stock dips while market gains: Key facts - MSN
Moderna says the FDA will consider its new flu shot after resolving a public dispute - Dayton Daily News
Moderna (MRNA) Stock Dips While Market Gains: Key Facts - Yahoo Finance
Moderna (NASDAQ:MRNA) Target Update Sparks Nasdaq 100 Index Focus - Kalkine Media
Barclays Analyst Raises Price Target for Moderna (MRNA) to $48.0 - GuruFocus
Moderna (NASDAQ:MRNA) Price Target Raised to $48.00 at Barclays - MarketBeat
Pfizer, BioNTech Halt Large US COVID-19 Vaccine Trial Over Slow Enrollment - BioSpace
Moderna, Inc. (NASDAQ:MRNA) Given Consensus Recommendation of "Reduce" by Brokerages - marketbeat.com
Moderna, Inc. Trade Ideas — BSESOF:0QF - TradingView
What's Going On With Pfizer Stock Wednesday?BioNTech (NASDAQ:BNTX), Pfizer (NYSE:PFE) - Benzinga
Moderna, Inc. Trade Ideas — EUROTLX:4MRNA - TradingView
Barclays Adjusts Price Target on Moderna to $48 From $25, Maintains Equalweight Rating - marketscreener.com
Moderna (MRNA) Valuation Check As Patent Dispute Settlement And Cancer Therapy Pivot Refocus Investor Attention - Yahoo Finance
Moderna, Pfizer Want Bayer's COVID-Shot Patent Suits Tossed - Law360
Moderna (MRNA) Experiences Bearish Sentiment Among Option Traders - GuruFocus
Oil Tumbles, Nasdaq 100 Jumps 3% As Iran Says It's Ready To Halt Hostilities: 10 Stocks Moving - Benzinga
Moderna, Pfizer Press to Toss Bayer’s Covid-Shot Patent Suits - Bloomberg Law News
Moderna 2.0: The mRNA Pioneer’s Pivot to Oncology and the Path to 2028 Profitability - FinancialContent
EMA Committee for Medicinal Products for Human Use Adopts Positive Opinion Recommending Authorization of Moderna's mNEXSPIKE (COVID-19 Vaccine, mRNA) - dnj.com
Moderna, Inc. (MRNA) Stock Forecasts - Yahoo Finance
3 Companies Built Their Fortunes on COVID Vaccines, but Only 1 Has a Real Plan for What Comes Next - 24/7 Wall St.
Moderna's Spikevax Vaccine: Current Market Position, Strategic Developments and Investor Relevance i - AD HOC NEWS
EMA panel recommendation for mCOMBRIAX approval sees Moderna stock fall 7.49% - Traders Union
MRNA Stock Quote Price and Forecast - CNN
Moderna (MRNA) Falls More Steeply Than Broader Market: What Investors Need to Know - Yahoo Finance
Moderna shares slide as investors weigh recent legal-cost clarity against fresh regulatory uncertainty - Quiver Quantitative
Stock Traders Purchase Large Volume of Moderna Call Options (NASDAQ:MRNA) - marketbeat.com
How (MRNA) Movements Inform Risk Allocation Models - Stock Traders Daily
ETFs Investing in Moderna, Inc. Stocks - TradingView
Azenta, 10x Genomics, PacBio, Oscar Health, and Moderna Shares Plummet, What You Need To Know - Yahoo Finance
What is behind Moderna stock's recent drop in value today - Traders Union
Vanguard realignment: Vanguard reports 0 MRNA shares (MRNA) - stocktitan.net
ImmunityBio vs. Moderna: Which Biotech Has More Upside Potential? - TradingView
Moderna Inc. stock: mRNA pioneer's strategic pivot amid biotech sector challenges and vaccine market - AD HOC NEWS
Moderna Stock is Soaring. Is It Too Late to Buy? - The Globe and Mail
Metagenomi Can’t Ax IPO Investor Suit Over Moderna Partnership - Bloomberg Law News
What is behind Moderna stock's recent gain in value today - tradersunion.com
Moderna stands as the best performing large-cap healthcare stock YTD (XLV:NYSEARCA) - Seeking Alpha
Moderna Receives Health Canada Approval for Updated COVID-19 Vaccine Targeting SARS-CoV-2 Variant LP.8.1 - Palm Beach Daily News
Moderna, Heidrick & Struggles Execs Talk AI Execution - WSJ
Moderna Inc. stock faces analyst pressure amid patent settlement with Arbutus Biopharma - ad-hoc-news.de
Moderna's Spikevax Vaccine: Current Status and Future Prospects in mRNA Technology Evolution - AD HOC NEWS
Lobbying Update: $100,000 of MODERNA INC. lobbying was just disclosed - Quiver Quantitative
Moderna Case Highlights Overlooked Hurdle In Biopharma IP - Law360
0.47%
0.44%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):